Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab.

被引：0
|
作者：
Ock, Chan-Young
An, Eunkyung
Oh, Do-Youn
Kim, Tae-Yong
Lee, Kyung-Hun
Han, Sae-Won
Im, Seock-Ah
Kim, Tae-You
Liao, Wei-Li
Cecchi, Fabiola
Blackler, Adele
Thyparambil, Sheeno P.
Hoos, William Arthur
Kim, Woo Ho
Burrows, Jon
Hembrough, Todd A.
Bang, Yung-Jue
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] OncoPlex Diagnost, Rockville, MD USA
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul 151, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4050
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A case of metastatic breast cancer with HER2 gene amplification that responded completely to single agent trastuzumab.
    Tsutani Y.
    Ohsumi S.
    Aogi K.
    Taira N.
    Kataoka M.
    Hamamoto Y.
    Nishimura R.
    Takashima S.
    Breast Cancer, 2006, 13 (4) : 374 - 377
  • [42] SERUM HER2 EXTRACELLULAR DOMAIN LEVELS AND TISSUE HER2 OVEREXPRESSION IN ADVANCED GASTRIC CANCER PATIENTS
    Takahashi, Y.
    Ohori, H.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 32 - 32
  • [43] Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
    Masakazu Toi
    Jeff Sperinde
    Weidong Huang
    Shigehira Saji
    John Winslow
    Xueguang Jin
    Yuping Tan
    Shinji Ohno
    Seigo Nakamura
    Hiroji Iwata
    Norikazu Masuda
    Kenjiro Aogi
    Satoshi Morita
    Christos Petropoulos
    Michael Bates
    BMC Cancer, 10
  • [44] Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
    Toi, Masakazu
    Sperinde, Jeff
    Huang, Weidong
    Saji, Shigehira
    Winslow, John
    Jin, Xueguang
    Tan, Yuping
    Ohno, Shinji
    Nakamura, Seigo
    Iwata, Hiroji
    Masuda, Norikazu
    Aogi, Kenjiro
    Morita, Satoshi
    Petropoulos, Christos
    Bates, Michael
    BMC CANCER, 2010, 10
  • [45] Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Jun Zhou
    Zhi Peng
    Yi Liu
    Jifang Gong
    Xiaotian Zhang
    Ming Lu
    Jing Gao
    Yili Li
    Yanyan Li
    Lin Shen
    Journal of Gastroenterology, 2016, 51 : 509 - 510
  • [46] Significance of Akt activation and compartmentalization for prediction of outcome in Her-2 positive breast cancer patients treated with trastuzumab.
    Svoboda, M.
    Grell, P.
    Fabian, P.
    Radova, L.
    Palacova, M.
    Nenutil, R.
    Vyzvla, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S173 - S173
  • [47] Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
    Duchnowska, Renata
    Sperinde, Jeff
    Czartoryska-Arlukowicz, Bogumila
    Mysliwiec, Paulina
    Winslow, John
    Radecka, Barbara
    Petropoulos, Christos
    Demlova, Regina
    Orlikowska, Marlena
    Kowalczyk, Anna
    Lang, Istvan
    Ziolkowska, Barbara
    Debska-Szmich, Sylwia
    Merdalska, Monika
    Grela-Wojewoda, Aleksandra
    Zawrocki, Anton
    Biernat, Wojciech
    Huang, Weidong
    Jassem, Jacek
    ONCOTARGET, 2017, 8 (61) : 104149 - 104159
  • [48] HER2-amplification level and tumor-infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab.
    Masini, Cristina
    Bisagni, Giancarlo
    Ragazzi, Moira
    Bisagni, Alessandra
    Dallaglio, Katiuscia
    Falco, Giuseppe
    Bassano, Cristina
    Ferrari, Guglielmo
    Gardini, Giorgio
    Bologna, Alessandra
    Moretti, Gabriella
    Boni, Corrado
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
    Caroline Rönnlund
    Emmanouil G. Sifakis
    Caroline Schagerholm
    Qiao Yang
    Emelie Karlsson
    Xinsong Chen
    Theodoros Foukakis
    Jodi Weidler
    Michael Bates
    Irma Fredriksson
    Stephanie Robertson
    Johan Hartman
    Breast Cancer Research, 26
  • [50] Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
    Wakatsuki, Takeru
    Yamamoto, Noriko
    Sano, Takeshi
    Chin, Keisho
    Kawachi, Hiroshi
    Takahari, Daisuke
    Ogura, Mariko
    Ichimura, Takashi
    Nakayama, Izuma
    Osumi, Hiroki
    Matsushima, Tomohiro
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Hiki, Naoki
    Ishikawa, Yuichi
    Yamaguchi, Kensei
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (11) : 1186 - 1195
12345